Concord Biotech Limited, a active public limited company, was established on 23 November 1984 in Ahmedabad, Gujarat, India. Engaging in chemical products within the manufacturing sector, it holds CIN: L24230GJ1984PLC007440. Registered under ROC Roc Ahmedabad. it is listed. It has an authorized capital of ₹11.00 Cr and a paid-up capital of ₹10.46 Cr.
Formerly known as Servomed Pharmaceuticals Private Limited, Servomed Pharmaceuticals Limited. It upholds a compliant status. In 2023, it reported revenue of ₹888.48 Cr and a net worth of ₹1,291.98 Cr. Employing 1,516 professional, Its leadership includes Arvind Motilal Agarwal (Director), Rajiv Ambrish Agarwal (Director), Bharti Khanna (Director). Past directors included Harcharan Singh, Om Dutt Tyagi, Yasir Yusufali Rawjee. It holds ₹45.00 Cr open charges and ₹154.77 Cr settled loans. Its latest AGM occurred on 09 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1482-86 Trasad Road Dholka, Ahmedabad, Gujarat, 387810.
L24230GJ1984PLC007440
007440
23 November 1984
₹11.00 Cr
₹10.46 Cr
Roc Ahmedabad
Listed
Active
Explore comprehensive insights into Concord Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arvind Motilal Agarwal | Director | 24 May 2022 | Current |
| Rajiv Ambrish Agarwal | Director | 30 Jun 2008 | Current |
| Bharti Khanna | Director | 31 Jan 2017 | Current |
| Amitabh Gajendra Thakore | Director | 31 Jan 2017 | Current |
| Chakravarthy Sriraman Mandayam | Director | 14 Jun 2022 | Current |
| Ravi Kapoor | Director | 15 Dec 2003 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Jul 2016 | Past |
| Pramod Abcsdd | Director | 21 Dec 2007 | Past |
| Pramod Abcsdd | Director | 04 Dec 2009 | Past |
| Pramod Abcsdd | Additional Director | 08 Jul 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2009 | Past |
| Pramod Abcsdd | Director | 04 Dec 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Concord Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.66% increase. The company also saw a substantial improvement in profitability, with a 33.35% increase in profit. The company's net worth Soared by an impressive increase of 16.69%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Concord Biotech had a promoter holding of 29.40% and a public holding of 70.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹450,000,000.00
₹1,547,675,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jan 2003 | Axis Bank Limited | ₹45.00 Cr | Open |
| 17 Oct 2019 | State Bank Of India | ₹110.00 Cr | Satisfied |
| 11 Aug 2015 | Citi Bank N.A. | ₹30.82 Cr | Satisfied |
| 09 Dec 2014 | Citi Bank N.A. | ₹10.00 Cr | Satisfied |
| 23 Jan 2012 | Citibank N. A. | ₹3.70 Cr | Satisfied |
Explore comprehensive loan charge details -
Concord Biotech has a workforce of 1516 employees as of Apr 14, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Concord Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Concord Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Concord Biotech Limited last Annual general meeting of members was held on 09 Sep 2025 as per latest MCA records. was documented.
Progress on A charge registered on 17 Oct 2019 via Charge ID 100298054 with State Bank Of India was fully satisfied on 29 May 2025. was documented.
Progress on Hina Ronak Patel was appointed as a Company Secretary was appointed as a Company Secretary on 15 May 2025 & has been associated with this company since 6 months 16 days . was documented.
The activity Concord Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
A charge with Axis Bank Limited of Rs. 45.00 Cr registered on 27 Jan 2003 with Charge ID 90099613 was modified on 31 Jul 2023. was recorded as a recent event.
The activity Chakravarthy Sriraman Mandayam was appointed as a Director was appointed as a Director on 14 Jun 2022 & has been associated with this company since 3 years 5 months . was completed.
The CIN of Concord Biotech Limited is L24230GJ1984PLC007440.
Concord Biotech Limited is headquartered at 1482-86 Trasad Road Dholka, Ahmedabad, Gujarat, 387810.
Concord Biotech Limited was incorporated on 23 November 1984.
The current directors of Concord Biotech Limited are
The primary industry of Concord Biotech Limited is Manufacturing.
Concord Biotech Limited is listed.
The authorized capital of Concord Biotech Limited is ₹11.00 Cr, and the paid-up capital is ₹10.46 Cr.
The compliance status of Concord Biotech Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX